Showing results (11-20 of 296) with videos related to

Sort By:
Pageof 30
European Heart Journal|December 22, 2012
Vitamin D and risk of death from vascular and non-vascular causes in the Whitehall study and meta-analyses of 12,000 deathsJoseph Tomson, Jonathan Emberson, Michael Hill, et al.
European Heart Journal|October 27, 2012
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection StudyJemma C Hopewell, Sarah Parish, Alison Offer, et al.
Journal of the American College of Cardiology|April 5, 2011
No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection studyJemma C Hopewell, Sarah Parish, Robert Clarke, et al.
Lancet (London, England)|November 12, 2010
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial, Jane Armitage, Louise Bowman, et al.
American Heart Journal|April 15, 2018
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetesLouise Bowman, Marion Mafham, William Stevens, et al.
Trials|March 4, 2023
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trialSarah Parish, Georgina Buck, Theingi Aung, et al.
Circulation|April 28, 2012
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection StudySarah Parish, Alison Offer, Robert Clarke, et al.
Circulation. Cardiovascular Quality and Outcomes|July 14, 2016
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare CostsSeamus Kent, Richard Haynes, Jemma C Hopewell, et al.
Lancet (London, England)|June 15, 2007
The safety of statins in clinical practiceJane Armitage
European Heart Journal|April 8, 2022
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trialSarah Parish, Marion Mafham, Alison Offer, et al.
Pageof 30